Genomic & Biopharma News

China’s Alphamab Oncology pulls off $100M series A
Alphamab Oncology has raised $100 million to advance a varied pipeline it says it inherited from Suzhou Alphamab. This includes compounds in development for infertility, ophthalmology and infection, but the biotech has flagged oncology as its focus.
Fierce Biotech, 2018-11-16 19:41:55

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

Study explains behavioral reaction to painful experiences
Findings provide new insights into how the body responds to harmful stimuli.
National Institutes of Health, 2018-11-16 19:00:00

New first-line treatment for peripheral T-cell lymphoma approved by FDA
The U.S. Food and Drug Administration today expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma.
News Medical Life Sciences, 2018-11-16 18:40:15

Personalized scheduling of radiotherapy using genetic data could reduce side effects
A new clinical study led by the University of Leicester and conducted in the HOPE clinical trials facility at Leicester's Hospitals has revealed the pivotal role that changing the time of day that a patient receives radiotherapy could play in altering radiotherapy toxicity.
News Medical Life Sciences, 2018-11-16 18:26:45

Researchers produce 3D chemical maps of small biological samples
Scientists at the National Synchrotron Light Source II --a U.S. Department of Energy (DOE) Office of Science User Facility at DOE's Brookhaven National Laboratory--have used ultrabright x-rays to image single bacteria with higher spatial resolution than ever before.
News Medical Life Sciences, 2018-11-16 18:11:52

EMA recommends first all-oral treatment to tackle deadly sleeping sickness
The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both stages of sleeping sickness.
News Medical Life Sciences, 2018-11-16 17:51:38

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

Gene editing could be used to halt kidney disease in patients with Joubert syndrome
For the first time scientists have identified how to halt kidney disease in a life-limiting genetic condition, which may pave the way for personalized treatment in the future.
News Medical Life Sciences, 2018-11-16 17:44:41

American Cancer Society study links social isolation to higher mortality risk
A large American Cancer Society study links social isolation with a higher risk of death from all causes combined and heart disease for all races studied, and with increased cancer mortality in white men and women.
News Medical Life Sciences, 2018-11-16 17:38:08

Long term exposure to road traffic noise linked with greater obesity risk
Long term exposure to road traffic noise is associated with increased risk of obesity. This was the conclusion of a study involving the participation of the Barcelona Institute for Global Health, a research center supported by the "la Caixa" Banking Foundation. The study has been published in Environment International.
News Medical Life Sciences, 2018-11-16 17:34:56